Pharmaceutical company GSK plans to invest £275m and says UK still ‘attractive’ post Brexit
According to the BBC, the giant GlaxoSmithKline is to invest £275m in the UK to expand its manufacturing sites. It claimed that, despite the referendum results, the UK’s skilled workforce and competitive tax system were critical for the decision.
For weekly news updates, subscribe to our email newsletter.
Related news: US Healthcare Companies Embrace Non-Traditional BPO